Crossmark

Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study

Crossref DOI link: https://doi.org/10.1186/s12884-022-05043-w

Published Online: 2022-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adan, Heba

Harb, Deemah

Hazari, Komal

Abdelkareem, Widad

Khan, Fareeda Nikhat

Zouaoui, Maryam

Raouf, May

Elsawy, Doaa

Azar, Aida Joseph

Khamis, Amar Hassan

Ammar, Abeer
License Information

Text and Data Mining valid from 2022-09-25

Version of Record valid from 2022-09-25
More Information

Article History

Received: 16 April 2022

Accepted: 8 September 2022

First Online: 25 September 2022

Declarations

:

: Prior to the commencement of the study, written informed consent was obtained from participants to receive convalescent plasma for treatment of their covid-19 infection. Ethical approval for publication of the study results was obtained from Dubai Scientific Research Ethics Committee (DSREC) of Dubai Health Authority (DHA) (Reference number:- DSREC-05/2021_14, dated 15 June 2021). All methods were carried out in accordance with relevant guidelines and regulations.

: No identifying data is included, so no consent for publication was required.

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below